<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-133025</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Early interruption of triple therapy with telaprevir in chronic hepatitis C due to severe adverse effects does not necessarily lead to treatment failure</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>López Nuñez, Carmen</dc:creator>
<dc:creator>Louvriex Freire, René</dc:creator>
<dc:creator>Ferri Iglesias, María José</dc:creator>
<dc:creator>Figa Francesch, Montserrat</dc:creator>
<dc:creator>Virolés Torrent, Silvia</dc:creator>
<dc:creator>Hombrados Verde, Manoli</dc:creator>
<dc:creator>Acero Fernández, Doroteo</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Gastroenterol Hepatol;38(2): 78-81, feb. 2015. tab</dc:source>
<dc:identifier>ibc-133025</dc:identifier>
<dc:title xml:lang="es">La interrupción precoz del tratamiento triple con telaprevir de la hepatitis crónica C por efecto adverso grave no presupone necesariamente el fracaso del tratamiento</dc:title>
<dc:subject>^d4404^s22012</dc:subject>
<dc:subject>^d33344^s22057</dc:subject>
<dc:subject>^d36291</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1002^s22020</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d1831^s22020</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>201502</dc:date>
</metadata>
</record>
</ibecs-document>
